Enhancement of insulin sensitivity, aiding in the regulation of glucose levels and mitigating the risk of type 2 diabetes. Reduction of hyperinsulinemia, addressing insulin-driven androgen production and symptoms associated with androgen excess. Management of metabolic complications, such as hyperinsulinemia and dyslipidemia, contributing to overall metabolic health improvement. Here, INS is linked to metabolic syndrome.